Skull Base Neoplasms
12
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 12 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (12)
Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
Surgical Outcomes of Extended Endoscopic Endonasal Approach for Skull Base Lesions.
Prospective Study of Sinonasal and Skull-base Tumours Management
Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery
ICG Angiogram as a Predictor of Postoperative Visual Function After EEA Surgery
Optic Nerve Stimulation To Prevent Visual Deficits After Endoscopic Cranial Approaches
Auditory Nerve Test System During Vestibular Schwannoma Resection
Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery
Proposal for Intraoperative Administration of Intravenous Indocyanine Green to Evaluate Position of the Optic Canal, Position of the Internal Carotid Arteries, Tumor Vascularization, and Vessel Encasement in Endoscopic Endonasal Cranial Base Surgery
Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery
Skull Base Reconstruction After Endonasal Cranio-endoscopic Resection Using Autologus Grafts
ICG Use in Angiography for Nasoseptal Flap Harvest